Health
Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT – News-Medical.Net
Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option.
Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option. This type of therapy, also called androgen deprivation therapy (ADT), reduces the level of testosterone and other androgens in the body. Lowering androgen levels can make prostate cancer cells grow more slowly or shrink tumors over time. However, patients receiving ADT often experience higher levels of fatigue, depression and cognitive impairment.
Moffitt Cancer Center…
-
Noosa News20 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?
-
Noosa News21 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business23 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025